We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Cellebrite
CLBT
$2.59B
| $3.94M | 0.02% |
+178,700
| New | +$3.44M |
|
477
Graco
GGG
$13.2B
| $3.94M | 0.02% |
46,690
-900
| -2% | -$78K |
|
478
Tapestry
TPR
$26.4B
| $3.93M | 0.02% |
60,146
+800
| +1% | +$43.7K |
|
479
Steel Dynamics
STLD
$37.6B
| $3.92M | 0.02% |
34,400
+800
| +2% | +$106K |
|
480
United Therapeutics
UTHR
$21.6B
| $3.92M | 0.02% |
11,100
-1,900
| -15% | -$698K |
|
481
Nutanix
NTNX
$17.7B
| $3.92M | 0.01% |
64,000
+5,700
| +10% | +$373K |
|
482
SoFi Technologies
SOFI
$23.6B
| $3.88M | 0.01% |
252,100
+25,500
| +11% | +$331K |
|
483
Comfort Systems
FIX
$61.4B
| $3.88M | 0.01% |
9,137
+1,500
| +20% | +$659K |
|
484
Labcorp
LH
$26.1B
| $3.87M | 0.01% |
16,877
-5,861
| -26% | -$1.34M |
|
485
Viatris
VTRS
$18.7B
| $3.86M | 0.01% |
309,800
-612,065
| -66% | -$7.52M |
|
486
News Corp Class A
NWSA
$15.6B
| $3.83M | 0.01% |
139,100
-9,600
| -6% | -$267K |
|
487
Regions Financial
RF
$27B
| $3.83M | 0.01% |
162,845
+43,866
| +37% | +$1.08M |
|
488
Revvity
RVTY
$13B
| $3.79M | 0.01% |
33,960
+1,600
| +5% | +$188K |
|
489
Kimco Realty
KIM
$16.3B
| $3.78M | 0.01% |
161,242
-16,500
| -9% | -$400K |
|
490
F5
FFIV
$23.7B
| $3.75M | 0.01% |
14,900
+400
| +3% | +$95.6K |
|
491
Citizens Financial Group
CFG
$31.3B
| $3.74M | 0.01% |
85,513
+10,913
| +15% | +$483K |
|
492
UDR
UDR
$12.1B
| $3.73M | 0.01% |
85,800
-4,100
| -5% | -$181K |
|
493
Akamai
AKAM
$18B
| $3.71M | 0.01% |
38,734
+12,248
| +46% | +$1.2M |
|
494
Pinterest
PINS
$12.9B
| $3.68M | 0.01% |
126,980
-29,020
| -19% | -$912K |
|
495
CarMax
KMX
$8.42B
| $3.67M | 0.01% |
44,900
-76,873
| -63% | -$6.04M |
|
496
Neurocrine Biosciences
NBIX
$15.5B
| $3.67M | 0.01% |
26,867
| – | – |
|
497
Lennox International
LII
$14.5B
| $3.66M | 0.01% |
6,000
| – | – |
|
498
Toast
TOST
$19.9B
| $3.64M | 0.01% |
99,900
+18,500
| +23% | +$650K |
|
499
C.H. Robinson
CHRW
$17.6B
| $3.64M | 0.01% |
35,200
+10,100
| +40% | +$1.09M |
|
500
Cincinnati Financial
CINF
$26.5B
| $3.62M | 0.01% |
25,185
+2,463
| +11% | +$360K |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.